Literature DB >> 24336162

The impact of the TIM gene family on tumor immunity and immunosuppression.

Muhammad Baghdadi1, Masahisa Jinushi2.   

Abstract

Tumor immunoevasion is an advanced phase of cancer immunosurveillance in which tumor cells acquire the ability to circumvent host immune systems and exploit protumorigenic inflammation. T-cell immunoglobulin mucin (TIM) gene family members have emerged as critical checkpoint proteins that regulate multiple immune response phases and maintain immune homeostasis. Accumulating evidence demonstrates that tumor cells exploit TIM gene family members to evade immunosurveillance, whereas TIM gene family members facilitate the prevention of inflammation-related tumor progression. Thus, a comprehensive analysis to clarify the relative contributions of TIM gene family members in tumor progression may elucidate immunosurveillance systems in cancer patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24336162      PMCID: PMC4002149          DOI: 10.1038/cmi.2013.57

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  70 in total

Review 1.  Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

Authors:  F M Marincola; E M Jaffee; D J Hicklin; S Ferrone
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

Review 2.  Immunobiology of the TAM receptors.

Authors:  Greg Lemke; Carla V Rothlin
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

3.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

4.  A new development of FG-CC' siRNA blocking interaction of Tim-1 and Tim-4 can enhance DC vaccine against gastric cancer .

Authors:  Hua-Wen Sun; Chong Wu; Hai-Yan Tan; Qiu-Shuang Wang
Journal:  Hepatogastroenterology       Date:  2012 Nov-Dec

5.  Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells.

Authors:  Sheng Xiao; Bing Zhu; Hulin Jin; Chen Zhu; Dale T Umetsu; Rosemarie H DeKruyff; Vijay K Kuchroo
Journal:  Eur J Immunol       Date:  2011-05-25       Impact factor: 5.532

6.  CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

Authors:  Susan E Erdman; Jane J Sohn; Varada P Rao; Prashant R Nambiar; Zhongming Ge; James G Fox; David B Schauer
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

Review 7.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

Review 8.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

9.  Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.

Authors:  Lucy Golden-Mason; Brent E Palmer; Nasim Kassam; Lisa Townshend-Bulson; Stephen Livingston; Brian J McMahon; Nicole Castelblanco; Vijay Kuchroo; David R Gretch; Hugo R Rosen
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

10.  TIM family proteins promote the lysosomal degradation of the nuclear receptor NUR77.

Authors:  Savithri Balasubramanian; Satya Keerthi Kota; Vijay K Kuchroo; Benjamin D Humphreys; Terry B Strom
Journal:  Sci Signal       Date:  2012-12-11       Impact factor: 8.192

View more
  14 in total

1.  The significance of TIMD4 expression in clear cell renal cell carcinoma.

Authors:  Hiromu Yano; Takanobu Motoshima; Chaoya Ma; Cheng Pan; Sohsuke Yamada; Toshiyuki Nakayama; Shohei Kitada; Naohiro Fujimoto; Tomomi Kamba; Motohiro Takeya; Yoshihiro Komohara
Journal:  Med Mol Morphol       Date:  2017-06-19       Impact factor: 2.309

Review 2.  Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses.

Authors:  Michael R Elliott; Kyle M Koster; Patrick S Murphy
Journal:  J Immunol       Date:  2017-02-15       Impact factor: 5.422

Review 3.  Blocking monoclonal antibodies of TIM proteins as orchestrators of anti-tumor immune response.

Authors:  Muhammad Baghdadi; Shintaro Takeuchi; Haruka Wada; Ken-Ichiro Seino
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

4.  Role of Transmembrane Protein 16F in the Incorporation of Phosphatidylserine Into Budding Ebola Virus Virions.

Authors:  Patrick Younan; Mathieu Iampietro; Rodrigo I Santos; Palaniappan Ramanathan; Vsevolod L Popov; Alexander Bukreyev
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

5.  Distinct role of Tim-3 in systemic lupus erythematosus and clear cell renal cell carcinoma.

Authors:  Hongying Zheng; Xingqing Guo; Qingwu Tian; Hui Li; Yuanqi Zhu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 6.  Accomplices of the Hypoxic Tumor Microenvironment Compromising Antitumor Immunity: Adenosine, Lactate, Acidosis, Vascular Endothelial Growth Factor, Potassium Ions, and Phosphatidylserine.

Authors:  Peter Vaupel; Gabriele Multhoff
Journal:  Front Immunol       Date:  2017-12-21       Impact factor: 7.561

7.  Expression of Tim-3 in peripheral blood mononuclear cells and placental tissue in unexplained recurrent spontaneous abortion.

Authors:  Xuewei Zhuang; Xiyan Xia; Lingxiao Liu; Yi Zhang; Xin Zhang; Chuanxin Wang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

8.  Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma.

Authors:  David F Bauer; Larisa Pereboeva; G Yancey Gillespie; Gretchen A Cloud; Osama Elzafarany; Catherine Langford; James M Markert; Lawrence S Lamb
Journal:  J Immunol Res       Date:  2016-08-17       Impact factor: 4.818

9.  TIM-4 is differentially expressed in the distinct subsets of dendritic cells in skin and skin-draining lymph nodes and controls skin Langerhans cell homeostasis.

Authors:  Xilin Zhang; Queping Liu; Jie Wang; Guihua Li; Matthew Weiland; Fu-Shin Yu; Qing-Sheng Mi; Jun Gu; Li Zhou
Journal:  Oncotarget       Date:  2016-06-21

10.  TIM-4 is expressed on invariant NKT cells but dispensable for their development and function.

Authors:  Xilin Zhang; Jun Gu; Li Zhou; Qing-Sheng Mi
Journal:  Oncotarget       Date:  2016-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.